-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Corrigendum: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Review: Clinical Trail Outcomes: Clinical Investigation